CapsoVision, Inc (CV) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$7.52M; Operating income (m); Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA -$7.04M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA -$7.41M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA -$7.97M; Operating income (m); Depreciation and amortization (m).
Complete source-backed ebitda history.
- Available history
- 2024-06-30 to 2026-06-30
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$7.52M | (m) | (m) | (m) | -206.48% | $0.00* | -$8.40M* | $1.77M | $5.31M | (m) | $0.00 |
|---|
| 2026-03-31 | Reported | -$7.04M | (m) | (m) | (m) | -252.04% | $48.00K | -$6.07M | $1.46M | $4.43M | (m) | $0.00 |
|---|
| 2025-12-31 | Reported | -$7.41M | (m) | (m) | (m) | -189.10% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | -$7.97M | (m) | (m) | (m) | -225.13% | $12.00K* | -$5.67M* | $1.62M | $6.09M | (m) | $0.00 |
|---|
| 2025-06-30 | Reported | -$4.6M | (m) | (m) | (m) | -138.64% | $30.00K* | -$4.53M* | $1.50M | $3.39M | (m) | $0.00 |
|---|
| 2025-03-31 | Reported | -$5.33M | (m) | (m) | (m) | -191.52% | $40.00K | -$4.99M | $1.29M | $3.11M | (m) | $0.00 |
|---|
| 2024-12-31 | Reported | -$4.58M | (m) | (m) | (m) | -132.76% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | -$5.75M | (m) | (m) | (m) | -193.90% | $4.00K* | -$7.06M* | $1.31M | $4.52M | (m) | $0.00 |
|---|
| 2024-06-30 | Reported | -$5.22M | (m) | (m) | (m) | -183.57% | (m) | (m) | $1.25M | $4.22M | (m) | $0.00 |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$25.3M | (m) | (m) | (m) | -186.66% | $90.00K | -$22.86M | $6.38M | $18.31M | (m) | $24.00K |
|---|
| 2024-12-31 | Reported | -$19.71M | (m) | (m) | (m) | -167.67% | $153.00K | -$20.09M | $5.38M | $15.12M | (m) | $11.00K |
|---|